Utility of Biomarkers in Cardiac Amyloidosis Pregenzer-Wenzler, Arianna; Abraham, Jo; Barrell, Kelsey ...
JACC. Heart failure,
September 2020, 2020-09-00, 20200901, Letnik:
8, Številka:
9
Journal Article
Recenzirano
Cardiac amyloidosis is a growing field, with advancements in diagnosis and management. Cardiac biomarkers are used to predict survival and to develop severity staging systems. Cardiac biomarkers are ...also used in clinical practice to stratify patients for treatment and to evaluate response to therapies. The current review summarizes the major clinical utility of current biomarkers in patients with cardiac amyloidosis and provides insights about future areas of investigation.
Display omitted
•Biomarkers can be used for patients with light chain amyloidosis and transthyretin amyloidosis for staging and prognosis.•Biomarkers can be used for patients with light chain amyloidosis to determine disease progression and response to therapies.•The role of biomarkers to determine disease progression and response to therapies in patient with transthyretin amyloidosis is an active area of investigation.
To improve patient safety, health care systems need reliable methods to detect adverse events in large patient populations. Events are often described in clinical notes, rather than structured data, ...which make them difficult to identify on a large scale.
To develop and compare 2 natural language processing methods, a rules-based approach and a machine learning (ML) approach, for identifying bleeding events in clinical notes.
This diagnostic study used deidentified notes from the Medical Information Mart for Intensive Care, which spans 2001 to 2012. A training set of 990 notes and a test set of 660 notes were randomly selected. Physicians classified each note as present or absent for a clinically relevant bleeding event during the hospitalization. A bleeding dictionary was developed for the rules-based approach; bleeding mentions were then aggregated to arrive at a classification for each note. Three ML models (support vector machine, extra trees, and convolutional neural network) were developed and trained using the 990-note training set. Another instance of each ML model was also trained on a sample of 450 notes, with equal numbers of bleeding-present and bleeding-absent notes. The notes were represented using term frequency-inverse document frequency vectors and global vectors for word representation.
The main outcomes were accuracy, sensitivity, specificity, positive predictive value, and negative predictive value for each model. Following training, the models were tested on the test set and sensitivities were compared using a McNemar test.
The 990-note training set represented 769 patients (296 38.5% female; mean SD age, 67.42 14.7 years). The 660-note test set represented 527 patients (211 40.0% female; mean SD age, 67.86 14.7 years). Bleeding was present in 146 notes (22.1%). The extra trees down-sampled model and rules-based approaches were similarly sensitive (93.8% vs 91.1%; difference, 2.7%; 95% CI, -3.8% to 7.9%; P = .44). The positive predictive value for the extra trees model, however, was 48.6%. The rules-based model had the best performance overall, with 84.6% specificity, 62.7% positive predictive value, and 97.1% negative predictive value.
Bleeding is a common complication in health care, and these results demonstrate an automated and scalable detection method. The rules-based natural language processing approach, compared with ML, had the best performance in identifying bleeding, with high sensitivity and negative predictive value.
Abstract only
Background:
Learning healthcare systems need techniques that can accurately and automatically identify health outcomes in large populations. Outcomes are often described in clinical ...narration in the electronic medical record.
Objective:
To develop and compare two natural language processing (NLP) approaches, rules-based (RB) and machine-learning (ML), for identifying bleeding events in clinical notes.
Methods:
We used de-identified notes from the Medical Information Mart for Intensive Care. We randomly selected 990 notes for a training set and 660 notes for a test set. Physicians classified each note as present or absent for a clinically relevant bleeding event during the hospitalization. We developed a dictionary of target and modifier words for the RB approach. In RB, the computer “reads” the text and tags bleeding targets as present or absent based on the modifier words; the mentions are aggregated to arrive at a classification for the note. For the ML approach, each note was represented as a high-dimensional vector where each dimension corresponds to the frequency of a certain word. Similar notes (e.g. bleeding present notes) have similar vectors; the computer learns these patterns to predict the class for an unseen note. One RB and three ML models (support vector machine (SVM), extra trees (ET), convolutional neural network (CNN)) were trained using the full 990-note training set. Another instance of each ML model was also trained on a down-sampled (DS) set of 450 notes, with equal positive and negative notes. We ran the trained models on the 660-note test set and compared classification performance using McNemar’s test.
Results:
The 660 note test set represented 527 unique patients, 40% female. Bleeding events were present in 21% of the notes. The ET-DS model was the most sensitive, followed by the RB approach (93.8% versus 91.1%, p=0.44). The PPV value for the ET-DS model, however, was <50%. The RB had the best performance overall, with 84.6% specificity, 62.7% positive predictive value, and 97.1% negative predictive value (NPV) for identifying clinically relevant bleeding.
Discussion:
A RB NLP approach, compared to ML, has the best overall performance in independently identifying bleeding events among critically ill patients. The current models have high NPV, so could be used to reduce the chart review burden.